作者: Tasuku Matsuoka , Masakazu Yashiro
关键词: Metastasis 、 Cell growth 、 Cancer research 、 Apoptosis 、 PI3K/AKT/mTOR pathway 、 Protein kinase B 、 RPTOR 、 Kinase 、 Signal transduction 、 Bioinformatics 、 Medicine
摘要: The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is one the key signaling pathways induced by various receptor-tyrosine kinases. Accumulating evidence shows that this an important promoter cell growth, metabolism, survival, metastasis, and resistance to chemotherapy. Genetic alterations in PI3K/Akt/mTOR gastric carcinoma have often been demonstrated. Many kinds molecular targeting therapies are currently undergoing clinical testing patients with solid tumors. However, exception ErbB2-targeting antibody, agents, including inhibitors, not approved for treatment carcinoma. This review summarizes current knowledge on pathogenesis possible therapeutic targets Improved will be useful understanding mechanisms tumor development identifying ideal anticancer therapy